Samuel R Denmeade (Samuel Denmeade)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 30

Top Topics

Benign Prostatic Hyperplasia

Radical Prostatectomy

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer research communications

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Sumer Jasmine, Adel Mandl, Timothy E G Krueger, Susan L Dalrymple, Lizamma Antony, Jennifer Dias, Cassandra A Celatka, Amy E Tapper, Maria Kleppe, Mayuko Kanayama, Yuezhou Jing, Valentina Speranzini, Yuzhuo Z Wang, Jun Luo, Bruce J Trock, Samuel R Denmeade, Michael A Carducci, Andrea Mattevi, Hugh Y Rienhoff, John T Isaacs, W Nathaniel Brennen
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models. The Prostate (2024)
Channing J Paller, Marianna L Zahurak, Adel Mandl, Nicole A Metri, Aliya Lalji, Elisabeth I Heath, William Kevin Kelly, Christopher J Hoimes, Pedro C Barata, Jason Taksey, Dominique A Garrison, Kartick Patra, Ginger L Milne, Nicole M Anders, Julie M Nauroth, Jennifer N Durham, Catherine Handy Marshall, Mark C Markowski, Mario A Eisenberger, Emmanuel S Antonarakis, Michael A Carducci, Samuel R Denmeade, Mark Levine
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial. Cancer research communications 4 (8) (2024)
Catherine Handy Marshall, Lukasz P Gondek, Violet Daniels, Changxue Lu, Sergiu Pasca, Jiajun Xie, Mark C Markowski, Channing J Paller, Laura A Sena, Samuel R Denmeade, Jun Luo, Emmanuel S Antonarakis
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer. The Prostate 84 (10) (2024)
Samuel R Denmeade
Resolute Progress Down a Long and Winding Road Leads to the Promised Land of Prostate-Specific Membrane Antigen-Based Therapies for Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (7) (2024)
Catherine Handy Marshall, Lukasz P Gondek, Violet Daniels, Changxue Lu, Sergiu Pasca, Jiajun Xie, Mark C Markowski, Channing J Paller, Laura A Sena, Samuel R Denmeade, Jun Luo, Emmanuel S Antonarakis
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer. The Prostate 84 (10) (2024)
Channing J Paller, Marianna L Zahurak, Adel Mandl, Nicole A Metri, Aliya Lalji, Elisabeth I Heath, William Kevin Kelly, Christopher J Hoimes, Pedro C Barata, Jason Taksey, Dominique A Garrison, Kartick Patra, Ginger L Milne, Nicole M Anders, Julie M Nauroth, Jennifer N Durham, Catherine Handy Marshall, Mark C Markowski, Mario A Eisenberger, Emmanuel S Antonarakis, Michael A Carducci, Samuel R Denmeade, Mark Levine
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial. Cancer research communications 4 (8) (2024)
Channing J Paller, Marianna L Zahurak, Adel Mandl, Nicole A Metri, Aliya Lalji, Elisabeth I Heath, William Kevin Kelly, Christopher J Hoimes, Pedro C Barata, Jason Taksey, Dominique A Garrison, Kartick Patra, Ginger L Milne, Nicole M Anders, Julie M Nauroth, Jennifer N Durham, Catherine Handy Marshall, Mark C Markowski, Mario A Eisenberger, Emmanuel S Antonarakis, Michael A Carducci, Samuel R Denmeade, Mark Levine
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase 2 Trial. Cancer research communications (2024)
Sumer Jasmine, Adel Mandl, Timothy E G Krueger, Susan L Dalrymple, Lizamma Antony, Jennifer Dias, Cassandra A Celatka, Amy E Tapper, Maria Kleppe, Mayuko Kanayama, Yuezhou Jing, Valentina Speranzini, Yuzhuo Z Wang, Jun Luo, Bruce J Trock, Samuel R Denmeade, Michael A Carducci, Andrea Mattevi, Hugh Y Rienhoff, John T Isaacs, W Nathaniel Brennen
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models. The Prostate 84 (10) (2024)
Samuel R Denmeade
Resolute Progress Down a Long and Winding Road Leads to the Promised Land of Prostate-Specific Membrane Antigen-Based Therapies for Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (7) (2024)
Sumer Jasmine, Adel Mandl, Timothy E G Krueger, Susan L Dalrymple, Lizamma Antony, Jennifer Dias, Cassandra A Celatka, Amy E Tapper, Maria Kleppe, Mayuko Kanayama, Yuezhou Jing, Valentina Speranzini, Yuzhuo Z Wang, Jun Luo, Bruce J Trock, Samuel R Denmeade, Michael A Carducci, Andrea Mattevi, Hugh Y Rienhoff, John T Isaacs, W Nathaniel Brennen
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models. The Prostate 84 (10) (2024)
Sumer Jasmine, Adel Mandl, Timothy E G Krueger, Susan L Dalrymple, Lizamma Antony, Jennifer Dias, Cassandra A Celatka, Amy E Tapper, Maria Kleppe, Mayuko Kanayama, Yuezhou Jing, Valentina Speranzini, Yuzhuo Z Wang, Jun Luo, Bruce J Trock, Samuel R Denmeade, Michael A Carducci, Andrea Mattevi, Hugh Y Rienhoff, John T Isaacs, W Nathaniel Brennen
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models. The Prostate (2024)
Samuel R Denmeade
Resolute Progress Down a Long and Winding Road Leads to the Promised Land of Prostate-Specific Membrane Antigen-Based Therapies for Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Sumer Jasmine, Adel Mandl, Timothy E G Krueger, Susan L Dalrymple, Lizamma Antony, Jennifer Dias, Cassandra A Celatka, Amy E Tapper, Maria Kleppe, Mayuko Kanayama, Yuezhou Jing, Valentina Speranzini, Yuzhuo Z Wang, Jun Luo, Bruce J Trock, Samuel R Denmeade, Michael A Carducci, Andrea Mattevi, Hugh Y Rienhoff, John T Isaacs, W Nathaniel Brennen
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models. The Prostate 84 (10) (2024)
Catherine Handy Marshall, Lukasz P Gondek, Violet Daniels, Changxue Lu, Sergiu Pasca, Jiajun Xie, Mark C Markowski, Channing J Paller, Laura A Sena, Samuel R Denmeade, Jun Luo, Emmanuel S Antonarakis
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer. The Prostate (2024)
Channing J Paller, Marianna L Zahurak, Adel Mandl, Nicole A Metri, Aliya Lalji, Elisabeth I Heath, William Kevin Kelly, Christopher J Hoimes, Pedro C Barata, Jason Taksey, Dominique A Garrison, Kartick Patra, Ginger L Milne, Nicole M Anders, Julie M Nauroth, Jennifer N Durham, Catherine Handy Marshall, Mark C Markowski, Mario A Eisenberger, Emmanuel S Antonarakis, Michael A Carducci, Samuel R Denmeade, Mark Levine
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial. Cancer research communications 4 (8) (2024)
Laura A Sena, Hao Wang, Samuel R Denmeade
First, do no harm: The unclear benefit of lifelong castration for patients with metastatic prostate cancer. The Prostate (2023)
Anqi Wang, Mariana Lazo, Jiayun Lu, David J Couper, Anna E Prizment, Mara Z Vitolins, Samuel R Denmeade, Corrine E Joshu, Elizabeth A Platz
Liver fibrosis scores and prostate cancer risk and mortality in the Atherosclerosis Risk in Communities (ARIC) Study. Cancer prevention research (Philadelphia, Pa.) (2023)
John T Isaacs, Susan L Dalrymple, Lizamma Antony, David Marc Rosen, Ilsa M Coleman, Peter S Nelson, Maya Kostova, Iain A Murray, Gary H Perdew, Samuel R Denmeade, Emmanuel S Akinboye, W Nathaniel Brennen
Third generation quinoline-3-carboxamide transcriptional disrupter of HDAC4, HIF-1α, and MEF-2 signaling for metastatic castration-resistant prostate cancer. The Prostate (2023)
Samuel R Denmeade, Laura A Sena, Hao Wang, Emmanuel S Antonarakis, Mark C Markowski
Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer. The oncologist (2023)
Samuel R Denmeade, Emmanuel S Antonarakis, Mark C Markowski
Bipolar androgen therapy (BAT): A patient's guide. The Prostate 82 (7) (2022)
Samuel R Denmeade, Su J Lim, Pedro Isaaccson Velho, Hao Wang
PSA provocation by bipolar androgen therapy may predict duration of response to first-line androgen deprivation: Updated results from the BATMAN study. The Prostate 82 (16) (2022)
Phuoc T Tran, Kathryn Lowe, Hua-Ling Tsai, Daniel Y Song, Arthur Y Hung, Jason W D Hearn, Steven Miller, James A Proudfoot, Matthew P Deek, Ryan Phillips, Tamara Lotan, Channing J Paller, Catherine Handy Marshall, Mark C Markowski, Shirl Dipasquale, Samuel R Denmeade, Michael Carducci, Mario A Eisenberger, Theodore L DeWeese, Matthew Orton, Curtiland Deville, Elai Davicioni, Stanley L Liauw, Elisabeth I Heath, Stephen Greco, Neil B Desai, Daniel E Spratt, Felix Y Feng, Hao Wang, Tomasz M Beer, Emmanuel S Antonarakis
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Rajendra Kumar, Janet Mendonca, Olutosin Owoyemi, Kavya Boyapati, Naiju Thomas, Suthicha Kanacharoen, Max Coffey, Deven Topiwala, Carolina Gomes, Busra Ozbek, Tracy Jones, Marc Rosen, Liang Dong, Sadie Wiens, W Nathaniel Brennen, John T Isaacs, Angelo M DeMarzo, Mark C Markowski, Emmanuel S Antonarakis, David Z Qian, Kenneth J Pienta, Drew M Pardoll, Michael A Carducci, Samuel R Denmeade, Sushant K Kachhap
Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer. Cancer research 81 (23) (2021)
Samuel R Denmeade, Hao Wang, Archana M Agarwal, David C Smith, Michael Thomas Schweizer, Mark N Stein, Vasileios Assikis, Przemyslaw W Twardowski, Thomas W Flaig, Russell Z Szmulewitz, Jeffrey M Holzbeierlein, Ralph J Hauke, Guru P Sonpavde, Jorge A Garcia, Arif Hussain, A Oliver Sartor, Shifeng S Mao, Harry Cao, Wei Fu, Ting Wang, Rehab Abdallah, Su Jin Lim, Vanessa Cilento, Channing J Paller, Michael A Carducci, Mark C Markowski, Mario A Eisenberger, Emmanuel S Antonarakis
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Mark C Markowski, Eugene Shenderov, Mario A Eisenberger, Sushant Kachhap, Drew M Pardoll, Samuel R Denmeade, Emmanuel S Antonarakis
Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer. The Prostate 80 (5) (2020)
Benjamin A Teply, Fang Qiu, Emmanuel S Antonarakis, Michael A Carducci, Samuel R Denmeade
Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU-AA-302. The Prostate 79 (8) (2020)
Oliver Rogers, Hung Yen, Anna Solomon, Charles Drake, Samuel R Denmeade
An IL-2 proaerolysin fusion toxin that selectively eliminates regulatory t cells to enhance antitumor immune response. The Prostate 79 (10) (2019)
Channing J Paller, Danilo Piana, James R Eshleman, Stacy Riel, Samuel R Denmeade, Pedro Isaacsson Velho, Steven P Rowe, Martin G Pomper, Emmanuel S Antonarakis, Jun Luo, Mario A Eisenberger
A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer. The Prostate 79 (14) (2019)
W Nathaniel Brennen, Michael Thomas Schweizer, Hao Wang, Trinity J Bivalacqua, Alan W Partin, Su Jin Lim, Carolyn Chapman, Rehab Abdallah, Oren Levy, Neil A Bhowmick, Jeffrey M Karp, Angelo De Marzo, John T Isaacs, Samuel R Denmeade
In Reply. Stem cells translational medicine 8 (7) (2019)
Maya B Kostova, William Nathaniel Brennen, David Lopez, Lizamma Anthony, Hao Wang, Elizabeth Platz, Samuel R Denmeade
PSA-alpha-2-macroglobulin complex is enzymatically active in the serum of patients with advanced prostate cancer and can degrade circulating peptide hormones. The Prostate 78 (11) (2018)